##gff-version 3
##sequence-region O95905 1 644
O95905	UniProtKB	Chain	1	644	.	.	.	ID=PRO_0000220844;Note=Protein ecdysoneless homolog	
O95905	UniProtKB	Region	439	644	.	.	.	Note=Transcription activation;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Region	481	497	.	.	.	Note=Involved in nuclear export;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Region	502	532	.	.	.	Note=Acidic region required for transactivation activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Modified residue	503	503	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
O95905	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
O95905	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18669648;Dbxref=PMID:17081983,PMID:18669648	
O95905	UniProtKB	Alternative sequence	262	304	.	.	.	ID=VSP_045670;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.3	
O95905	UniProtKB	Alternative sequence	375	375	.	.	.	ID=VSP_045671;Note=In isoform 3. E->ERLEVQWRDPGLLQAPPPGFTPFICLSLLSTWDN;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O95905	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_051970;Note=R->Q;Dbxref=dbSNP:rs3812619	
O95905	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_012191;Note=Could be a rare polymorphism. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11090341;Dbxref=dbSNP:rs151023501,PMID:11090341	
O95905	UniProtKB	Natural variant	452	452	.	.	.	ID=VAR_051971;Note=E->Q;Dbxref=dbSNP:rs3736518	
O95905	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_051972;Note=N->S;Dbxref=dbSNP:rs36152134	
O95905	UniProtKB	Natural variant	634	634	.	.	.	ID=VAR_051973;Note=D->G;Dbxref=dbSNP:rs2271904	
O95905	UniProtKB	Mutagenesis	481	481	.	.	.	Note=Decreases transactivation activity. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	484	484	.	.	.	Note=Decreases transactivation activity. D->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	489	489	.	.	.	Note=Decreases transactivation activity. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	503	503	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-505%2C A-518%2C A-572%2C A-579 and A-584. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Mutagenesis	505	505	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-503%2C A-518%2C A-572%2C A-579 and A-584. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Mutagenesis	510	510	.	.	.	Note=Increases transactivation activity. D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	512	512	.	.	.	Note=Increases transactivation activity. D->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	518	518	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-503%2C A-505%2C A-572%2C A-579 and A-584. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Mutagenesis	520	520	.	.	.	Note=Increases transactivation activity. D->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19919181;Dbxref=PMID:19919181	
O95905	UniProtKB	Mutagenesis	572	572	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-503%2C A-505%2C A-518%2C A-579 and A-584. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Mutagenesis	579	579	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-503%2C A-505%2C A-518%2C A-572 and A-584. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Mutagenesis	584	584	.	.	.	Note=Greatly impairs in vitro phosphorylation by CK2 and impairs cell cycle regulation activity%3B when associated with A-503%2C A-505%2C A-518%2C A-572 and A-579. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26711270;Dbxref=PMID:26711270	
O95905	UniProtKB	Sequence conflict	28	28	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95905	UniProtKB	Sequence conflict	319	319	.	.	.	Note=F->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95905	UniProtKB	Sequence conflict	333	333	.	.	.	Note=W->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
